| |
| |
|
| Insider
Information: |
Potter Stephen W |
| Relationship: |
Chief Business Officer |
| City: |
Columbia |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
18,091 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$83,361 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,091 |
|
|
| Total
Value |
$83,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -49.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Osiris Therapeutics, Inc. |
OSIR |
Officer |
2011-02-07 |
4,075 |
|
0 |
Premium* |
|
|
Lisata Therapeutics Ord Shs |
LSTA |
Executive Vice President |
2014-12-31 |
14,016 |
2013-02-11 |
0 |
Premium* |
|
|
Applied Genetic Technologies Corp |
AGTC |
Chief Business Officer |
2022-11-30 |
0 |
2016-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGTC |
Applied Genetic Technolog... |
Chief Business Officer |
• – – |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,750) |
0 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Chief Business Officer |
• – – |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,133) |
8,750 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Chief Business Officer |
• – – |
2022-07-01 |
4 |
S |
$0.77 |
$6,250 |
D/D |
(8,070) |
55,883 |
0 |
% |
|
| AGTC |
Applied Genetic Technolog... |
Chief Business Officer |
• – – |
2021-08-15 |
4 |
D |
$3.58 |
$20,492 |
D/D |
(5,724) |
63,953 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Chief Business Officer |
• – – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
69,677 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
VP and Chief Business Officer |
• – – |
2020-08-15 |
4 |
D |
$5.77 |
$33,022 |
D/D |
(5,723) |
34,677 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
VP and Chief Business Officer |
• – – |
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,000 |
40,400 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
See Remarks |
• – – |
2016-09-20 |
4 |
B |
$8.69 |
$3,476 |
D/D |
400 |
1,400 |
2.66 |
- |
|
| AGTC |
Applied Genetic Technolog... |
See Remarks |
• – – |
2016-09-16 |
4 |
B |
$8.97 |
$8,970 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Executive Vice President |
• – – |
2014-12-31 |
4 |
A |
$3.20 |
$2,951 |
D/D |
921 |
14,016 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Executive Vice President |
• – – |
2014-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,303 |
12,835 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Executive Vice President |
• – – |
2014-06-30 |
4 |
A |
$5.54 |
$2,948 |
D/D |
532 |
6,532 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2013-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Senior Vice PresidentOfficer |
• – – |
2011-02-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,075 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
